586 related articles for article (PubMed ID: 25967740)
21. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
Kwon JY; Daoud ND; Hashash JG; Picco MF; Farraye FA
Inflamm Bowel Dis; 2023 Feb; 29(2):254-259. PubMed ID: 35468183
[TBL] [Abstract][Full Text] [Related]
23. High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study.
Haykir Solay A; Eser F
Hum Vaccin Immunother; 2019; 15(5):1177-1182. PubMed ID: 30676860
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination.
Cossio-Gil Y; Martínez-Gómez X; Campins-Martí M; Rodrigo-Pendás JÁ; Borruel-Sainz N; Rodríguez-Frías F; Casellas-Jordà F
J Gastroenterol Hepatol; 2015 Jan; 30(1):92-8. PubMed ID: 25160690
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease.
Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH
Inflamm Bowel Dis; 2014 Jan; 20(1):69-74. PubMed ID: 24284413
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B vaccination in patients with inflammatory bowel disease.
Ben Musa R; Gampa A; Basu S; Keshavarzian A; Swanson G; Brown M; Abraham R; Bruninga K; Losurdo J; DeMeo M; Mobarhan S; Shapiro D; Mutlu E
World J Gastroenterol; 2014 Nov; 20(41):15358-66. PubMed ID: 25386085
[TBL] [Abstract][Full Text] [Related]
27. Acute hepatitis B virus infection despite vaccination in a patient treated by infliximab: a case report.
Besombes J; Souala F; Bouguen G; Guyader D; Grolhier C; Thibault V; Pronier C
BMC Gastroenterol; 2022 Jun; 22(1):322. PubMed ID: 35768794
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Clinical Outcomes After Switching from Remicade
Smits LJT; Grelack A; Derikx LAAP; de Jong DJ; van Esch AAJ; Boshuizen RS; Drenth JPH; Hoentjen F
Dig Dis Sci; 2017 Nov; 62(11):3117-3122. PubMed ID: 28667429
[TBL] [Abstract][Full Text] [Related]
29. The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines.
Wilckens V; Kannengiesser K; Hoxhold K; Frenkel C; Kucharzik T; Maaser C
Scand J Gastroenterol; 2011 Jul; 46(7-8):855-61. PubMed ID: 21506630
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
31. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
32. Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease.
Binkhorst L; Sobels A; Stuyt R; Westerman EM; West RL
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):699-703. PubMed ID: 29538037
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689
[TBL] [Abstract][Full Text] [Related]
34. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Schneeweiss S; Korzenik J; Solomon DH; Canning C; Lee J; Bressler B
Aliment Pharmacol Ther; 2009 Aug; 30(3):253-64. PubMed ID: 19438424
[TBL] [Abstract][Full Text] [Related]
35. Immune response to hepatitis B vaccine in health-care workers.
Zamani F; Fallahian F; Hashemi F; Shamsaei Z; Alavian SM
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):179-84. PubMed ID: 21196642
[TBL] [Abstract][Full Text] [Related]
36. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
Shapiro AJ; Esther CR; Leigh MW; Dellon EP
Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
[TBL] [Abstract][Full Text] [Related]
37. Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis.
Clemmensen K; Akrawi N; Stawowy M
Scand J Gastroenterol; 2015; 50(12):1508-11. PubMed ID: 26133362
[TBL] [Abstract][Full Text] [Related]
38. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
Waszczuk E; Waszczuk KM; Mulak A; Paradowski L
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero.
de Lima A; Kanis SL; Escher JC; van der Woude CJ
J Crohns Colitis; 2018 Jul; 12(8):948-953. PubMed ID: 29726943
[TBL] [Abstract][Full Text] [Related]
40. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
